Long survival in a pancreatic carcinoma patient with multi-organ toxicities after sintilimab treatment: A case report

Pancreatic carcinoma is the leading cause of death among digestive malignancies in China. In particular, there is no breakthrough in prolonging the survival of pancreatic cancer patients with chemical and targeted therapies. Tumor immunotherapy brings opportunities and progress for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Chen-Xu, Zhao, Yu, Qian, Hong, Fu, Hui, Yan, Yu-Ying, Qiu, Yu-Shuang, Zhou, Can-Can, Huang, Fang, Shen, Fu-Ming, Li, Dong-Jie, Xu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894891/
https://www.ncbi.nlm.nih.gov/pubmed/36744247
http://dx.doi.org/10.3389/fphar.2023.1121122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894891/
https://www.ncbi.nlm.nih.gov/pubmed/36744247
http://dx.doi.org/10.3389/fphar.2023.1121122

Ejemplares similares